Abstract Details
Adam De Havenon, MD, FAAN
(Yale University)
PRESENTER |
Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
Alen Delic | Alen Delic has nothing to disclose. |
No disclosure on file | |
Vivek Reddy, MD (University of Utah) | Dr. Reddy has nothing to disclose. |
No disclosure on file | |
Jennifer J. Majersik, MD, FAAN (University of Utah) | Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS. |
Christopher Orlando, MD, MPH (Keck School of Medicine of USC) | The institution of Dr. Orlando has received research support from National Institutes of Health. |